Expanding treatment options for rosacea
- 18 March 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (3), 412-413
- https://doi.org/10.1111/bjd.18985
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A multicentre, randomized, double‐masked, parallel group, vehicle‐controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosaceaBritish Journal of Dermatology, 2020
- What Is the Evidence for Co-trimoxazole, Clindamycin, Doxycycline, and Minocycline in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia?Annals of Pharmacotherapy, 2019
- Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosaceaBritish Journal of Dermatology, 2018
- A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular RosaceaJournal of Investigative Dermatology, 2016
- Rosacea: The Blessing of the Celts – An Approach to Pathogenesis Through Translational ResearchActa Dermato-Venereologica, 2016
- Interventions for rosaceaEmergencias, 2015
- Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literatureAmerican Journal of Physiology-Cell Physiology, 2010
- Increased serine protease activity and cathelicidin promotes skin inflammation in rosaceaNature Medicine, 2007